AC Immune (ACIU) Divestments (2015 - 2025)
AC Immune (ACIU) posted quarterly Divestments of $186.3 million for Q3 2025, up 212.21% year-over-year from $59.7 million in Q3 2024, and up 529.85% quarter-over-quarter from $29.6 million in Q1 2025.
AC Immune (ACIU) Divestments (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Divestments for 11 consecutive years, with $186.3 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Divestments rose 212.21% year-over-year to $186.3 million; the TTM figure through Sep 2025 stood at $22.8 million (up 112.37% YoY), while the FY2016 annual figure was -$114753.9, up 54.77% from the prior year.
- Divestments advanced to $186.3 million in Q3 2025 per ACIU's latest filing, from $29.6 million in the prior quarter.
- Across five years, Divestments topped out at $186.3 million in Q3 2025 and bottomed at -$166.0 million in Q3 2024.
- Historically, Divestments has averaged $2.5 million across 5 years, with a median of -$873786.7 in 2021.
- Annual changes were most pronounced in 2021 — Divestments sank 436.57% — and 2023, when it soared 8013.88%.
- AC Immune's Divestments stood at -$26.9 million in 2021, then slumped by 40.99% to -$37.9 million in 2022, then surged by 222.21% to $46.3 million in 2023, then plunged by 458.75% to -$166.0 million in 2024, then soared by 212.21% to $186.3 million in 2025.
- Business Quant data shows ACIU's Divestments at $186.3 million in Q3 2025, $29.6 million in Q1 2025, and -$166.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 9.82 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -13.21 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 186.27 Mn |
| Mar 31, 2025 | 29.57 Mn |
| Sep 30, 2024 | -166.01 Mn |
| Mar 31, 2024 | -26.99 Mn |
| Mar 31, 2023 | 46.27 Mn |
| Sep 30, 2022 | -37.86 Mn |
| Jun 30, 2022 | 58.05 Mn |
| Mar 31, 2022 | -584,716.52 |
| Sep 30, 2021 | -26.86 Mn |
| Jun 30, 2021 | -33.62 Mn |
| Mar 31, 2021 | -873,786.66 |
| Sep 30, 2020 | 16.02 Mn |
| Jun 30, 2020 | 9.99 Mn |
| Mar 31, 2020 | -219,175.48 |
| Sep 30, 2019 | -10.61 Mn |
| Jun 30, 2019 | -338,087.38 |
| Mar 31, 2019 | -50.72 Mn |
| Sep 30, 2018 | -141,278.09 |
| Jun 30, 2018 | -416,541.53 |
| Mar 31, 2018 | -1.22 Mn |